Background illustration for clinical trials search

Paid Clinical Trials Oklahoma

Discover 700 paid clinical trials in Oklahoma. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Oklahoma City OK
Sponsor: Sorrento Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05007418

Phase 1, Recruiting

Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer

for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Providence RI, Worcester MA, New York NY, Sewell NJ,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT06388018

Phase 2, Recruiting

Outcomes in Simulated Endoscopy Training

for
Impact of Supervision on Endoscopy Simulation Curriculum
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 22 - 50

Code: NCT03495141

Recruiting

Liver Cancer Disparities in American Indian and Alaska Native Persons

for
Hepatocellular Carcinoma, Cirrhosis, Liver, Hepatitis B
Location: Tahlequah OK
Sponsor: University of Washington

Sex: All

Age: 18 - 70+

Code: NCT05304234

Phase 2, Recruiting

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

for
Venous Thromboembolism, Deep Venous Thrombosis,
Location: Providence RI, New Haven CT, Bay Shore NY, Brooklyn NY,
Sponsor: Inari Medical

Sex: All

Age: 18+

Code: NCT05701917

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress

for
Covid19
Location: Brandon FL, Sarasota FL, Tulsa OK, Mesquite TX,
Sponsor: Sorrento Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04905836

Phase 2, Recruiting

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

for
Recurrent or Refractory Solid Tumors, Ewing Sarcoma,
Location: Cincinnati OH, Milwaukee WI, Dallas TX,
Sponsor: South Plains Oncology Consortium

Sex: All

Age: 1 - 20

Code: NCT02013336

Phase 1, Recruiting

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

for
Cystic Fibrosis
Location: Boston MA, Valhalla NY, New York NY, Burlington VT,
Sponsor: Sonya Heltshe

Sex: All

Age: 0 - 10

Code: NCT04509050

Recruiting

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

for
Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell,
Location: Philadelphia PA, Miami FL, Buffalo NY, Cleveland OH,
Sponsor: Oncotartis, Inc.

Sex: All

Age: 18+

Code: NCT03921879

Phase 1, Recruiting

Low Level Tragus Stimulation in Acute Decompensated Heart Failure

for
Acute Decompensated Heart Failure
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 70+

Code: NCT02898181

Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: New Haven CT, New York NY, Montreal, Philadelphia PA,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase 3, Recruiting

Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0

for
Obesity in Pregnancy, Labor Complication
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: Female

Age: 15 - 45

Code: NCT06488781

Phase 2, Recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, New York NY, Toronto, Sarasota FL,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06752681

Phase 1, Recruiting

The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease

for
Claudication, Peripheral Artery Disease
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 40+

Code: NCT05712395

Recruiting

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

for
Advanced Malignant Solid Neoplasm,
Location: Boston MA, New Haven CT, Trumbull CT, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06311214

Phase 2, Recruiting

Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing Homelessness

for
Alcohol Misuse, Homeless
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 18+

Code: NCT06821295

Phase 2, Phase 3, Recruiting

Evaluation of the MuSICCA for Measuring Awareness

for
Disorder of Consciousness
Location: Atlanta GA, Bethany OK
Sponsor: The Children's Trust, United Kingdom

Sex: All

Age: 2 - 18

Code: NCT04050995

Recruiting

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: New York NY, Baltimore MD, Tampa FL, Ann Arbor MI,
Sponsor: Tvardi Therapeutics, Incorporated

Sex: All

Age: 18+

Code: NCT05440708

Phase 1, Phase 2, Recruiting

Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke

for
Ischemic Stroke
Location: Hershey PA, Louisville KY, Mobile AL, Winfield IL,
Sponsor: University of Tennessee

Sex: All

Age: 18+

Code: NCT03728738

Phase 3, Recruiting

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)

for
Necrotizing Enterocolitis
Location: New Haven CT, Hershey PA, Pittsburgh PA, Tampa FL,
Sponsor: Noveome Biotherapeutics, formerly Stemnion

Sex: All

Age: 0

Code: NCT06315738

Phase 1, Phase 2, Recruiting

Popular cities in Oklahoma

NormanEdmondTulsaOklahoma City